GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Price-to-Funds-From-Operations

Kangstem Biotech Co (XKRX:217730) Price-to-Funds-From-Operations : (As of May. 02, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Kangstem Biotech Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Kangstem Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
512 Teheran-ro, Gangnam-gu, 17th Floor, Sinan Building, Seoul, KOR
Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.